chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, Interchange of vaccine products, SARS-CoV-2 test
Clinical narrative: COVID 19; COVID 19; I was vaccinated twice (Both Pfizer and Moderna); This is a spontaneous report received from a non-contactable reporter (Consumer). The reporter is the patient.  A 52-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Feb2023 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 52 years for covid-19 immunisation; BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), in Feb2023 as dose number unknown (booster), single (Batch/Lot number: unknown) and as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "I was vaccinated twice (Both Pfizer and Moderna)". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient was treated with Paxlovid. Patient was not immunocompromised in any way. Patient was vaccinated twice (Both Pfizer and Moderna) and boosted twice (booster in Feb2023).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: Stroke; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2023NVX-US-000000360 (Novavax).  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "Stroke". Follow-up attempts are completed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: I had a nasal infection for several years. The doctors tried everything. About two weeks after I had my first Covid-19 Vac. my infection went away.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP), Program ID: The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (COVID-19 VACCINE NOS MANUFACTURER UNKNOWN), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "I had a nasal infection" (unspecified if ongoing), notes: I had a nasal infection for several years. The patient's concomitant medications were not reported.  The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "I had a nasal infection for several years. The doctors tried everything. About two weeks after I had my first Covid-19 Vac. my infection went away.".  Additional information: Patient had a nasal infection for several years. The doctors tried everything. About two weeks after patient had first Covid-19 Vac. infection went away. patient had two more boosters. The infection is still gone.  Follow-up attempts are completed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Rheumatoid arthritis
Clinical narrative: I'm now suffering from full blown Ra; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RHEUMATOID ARTHRITIS (medically significant), outcome "unknown", described as "I'm now suffering from full blown Ra".  Clinical course: Patient had took shots because of covid 19 why am I'm now suffering from full blown Ra I was fine could do anything now I'm going to hell in a hand basket.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: M
Vaccine: PNC20
Symptoms: Allergy to vaccine
Clinical narrative: had an allergy to the yellow fever vaccine; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A male patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALLERGY TO VACCINE (non-serious), outcome "unknown", described as "had an allergy to the yellow fever vaccine". The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.  Additional information: Patient calling for Prevnar 20 and the patient said he had an allergy to the yellow fever vaccine. He wanted to know more about this or ask for more information.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient.  An elderly female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunisation. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Sick".  Additional information: The first booster made her sick.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: made me sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient.  An adult female patient received BNT162b2, as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "made me sick".  Additional information: Patient haven't had the chance to get it done. With her other vaccinations they made her sick and she don't have the time to be sick again.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: got covid three times and was hospital twice; got covid three times and was hospital twice; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An elderly female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Covid" (unspecified if ongoing), notes: I got covid three times and was hospitalized twice-once prior to vaccine. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (hospitalization, medically significant), SUSPECTED COVID-19 (hospitalization, medically significant), outcome "unknown" and all described as "got covid three times and was hospital twice". Patient got covid three times and was hospitalized twice - once prior to vaccine, then months after vaccine. And again months after having it for the second time. The original did nothing and the autoimmunity gave me the weakest case of the three.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300166044 Same patient/event, different vaccine dose;
Sex: M
Vaccine: COVID19
Symptoms: Neoplasm malignant
Clinical narrative: cancer; This is a spontaneous report received from a non-contactable reporter(s) (Consumer).  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: NEOPLASM MALIGNANT (medically significant), outcome "unknown", described as "cancer". Therapeutic measures were taken as a result of neoplasm malignant. Clinical information: It was reported that the wife (reported) asked where they could find the Pfizer COVID-19 vaccine for the patient since he needed to start all over again. She said that the patient had it long time ago and now he was a cancer patient who had just a bone marrow transplant.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 0.33
Sex: F
Vaccine: IPV
Symptoms: No adverse event, Poor quality product administered, Product storage error
Clinical narrative: Temperature excursion with no reported adverse event; Administration of punctured Ipol after excursion with no reported adverse event; Initial information received on 13-Apr-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case is linked to cases 2023SA119119 and 2023SA119126.  This case involves a 4 months old female patient and is reported administration of punctured IPV (VERO) [IPOL] after excursion and temperature excursion with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HIB vaccine CONJ (TET TOX) (Hiberix), pneumococcal vaccine CONJ 13V (CRM197) (Prevnar 13); diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTAP); and Rotavirus Vaccine for Prophylactic vaccination.  On 28-Mar-2023, the patient received a DOSE 2 dose 0.5 ml of suspect IPV (VERO) Suspension for injection lot V1B901M expiry date: 06-Feb-2024 via intramuscular route in the right thigh for Immunization or TB skin test.  On 28-MAR-2023 the patient developed a non-serious event "administration of punctured ipol after excursion with no reported adverse event" (poor quality product administered) and on an unknown date temperature excursion with no reported adverse event (product storage error) on the same day following the administration of IPV (VERO).  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  US-SA-2023SA119943:
Age: 1.25
Sex: U
Vaccine: HIBV
Symptoms: Medication error, No adverse event, Wrong product administered
Clinical narrative: acthib that was a given to a 15 month old patient instead of pentacel with no reported adverse event; Initial information received on 18-Apr-2023 regarding an unsolicited valid  non-serious case received via pharmacist.  This case involves 15 month old patient who was  given acthib [Act-Hib] instead of pentacel with no reported adverse event.  The patient's past medical history, medical treatment(s), concomitant(s) and family history were not provided.   On an unknown date, the patient received suspect HIB (PRP/T) VACCINE Powder and solvent for solution for injection dose series 4 at dose 0.5 ml (strength, route, batch number, expiry date:unknown via unknown route in unknown administration site for prophylactic vaccination (immunization).  On an unknown date , acthib  was a given to a 15 month old patient instead of pentacel (wrong product administered) same day latency with no reported adverse event.  Action taken was not applicable.  At time of reporting, the outcome was Unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: DTAPIPVHIB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Dosing series of PENTACEL was skipped and another MEDICINE was given with no reported AE; Initial information received on 18-Apr-2023 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves a 15 months old and unknown gender patient who had dosing series of pentacel was skipped and another medicine was given with no reported ae after receiving vaccine diphtheria/tetanus/5 hybrid ac pertussis/ipv(mrc5)/hib(prp/t) vaccine [pentacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/ipv(mrc5)/hib(prp/t) vaccine Suspension for injection (strength, expiration date and lot number not reported via unknown route in unknown administration site for Immunization.  On an unknown date the patient developed a non-serious event dosing series of pentacel was skipped and another medicine was given with no reported ae (inappropriate schedule of product administration) (unknown latency).  Action taken was not applicable.  Outcome: Unknown for the event dosing series of pentacel was skipped and another medicine was given with no reported ae.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired dose of quadracel was administered with no adverse event reported; Initial information was received on 18-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 4 years old male patient who stated expired dose of quadracel was administered with no adverse event after receiving diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine [Quadracel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included measles vaccine LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), rubella vaccine LIVE (WISTAR RA 27/3), VARICELLA zoster vaccine live (OKA/MERCK) (Proquad) for Prophylactic vaccination.  On 17-Apr-2023, the patient received 0.5 ml once, Total dose of suspect diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine (Suspension for injection) (lot C5851AA, expiry date: 25-Mar-2023), (strength: Standard) via unknown route in the left deltoid for Immunization.  On 17-Apr-2023 the patient developed a non-serious event of expired dose of quadracel was administered with no adverse event reported (expired product administered) same day following the administration of diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine.  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: YF
Symptoms: No adverse event, Product preparation error
Clinical narrative: used Sterile water as diluent for YF- VAX that was administered to a patient instead of using supplied diluent with no reported adverse event; Initial information received on 18-Apr-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient who had used sterile water as diluent for yf- vax that was administered to a patient instead of using supplied diluent with no reported adverse event after receiving vaccine Yellow fever vaccine  [yf-vax].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect yellow fever vaccine Solution for injection (strength, dose, expiration date and lot number not reported) via unknown route in unknown administration site for immunization.  On an unknown date the patient developed a non-serious event used sterile water as diluent for yf- vax that was administered to a patient instead of using supplied diluent with no reported adverse event (product preparation error) (unknown latency).  A Nurse called and reported that they used Sterile water as diluent for the YF- VAX that was administered to a patient instead of using the supplied diluent (0.6 ml single dose vial of Sodium Chloride Injection USP for single dose vial of vaccine). Caller wants to know if the YF-VAX that they administered was counted as valid and if they need to do a revaccination.  Lab data was not reported.  Action taken was not applicable.  Outcome: Unknown for the event used sterile water as diluent for yf- vax that was administered to a patient instead of using supplied diluent with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 3.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Medication error, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: quadracel was administered to a three year old patient with no reported adverse reaction; Initial information received  on 19-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 3 years old male patient who had quadracel was administered to a three year old patient with no reported adverse reaction after receiving vaccine diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine [quadracel].  The patient's has no past vaccination(s). The patient's past medical history, medical treatment(s), and family history were not provided.  On 19-Apr-2023, the patient received a dose 4, 0.5 ml once of suspect diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine Suspension for injection lot C6002BA, expiration date 18-May-2024 via intramuscular route in unknown administration site for immunization.  On 19-APR-2023 the patient developed a non-serious event quadracel was administered to a three year old patient with no reported adverse reaction (product administered to patient of inappropriate age) (latency: same day).  Lab data was not reported.  Action taken was not applicable.  Outcome: Unknown for the event quadracel was administered to a three year old patient with no reported adverse reaction.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.33
Sex: M
Vaccine: MNQ
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: menactra was administered to a patient of age 4 month with no adverse event; Initial information was received on 20-Apr-2023 regarding an unsolicited valid non-serious case from a physician.  This case involves a meningococcal a-c-y-w135 (d conj) vaccine [Menactra] was administered to 4 months old male patient with no adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included diphtheria vaccine toxoid, hib vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid (Pentacel) for Prophylactic vaccination (Immunisation) and Rotovax.   On 19-Apr-2023, the patient of age 4 months received a dose of 0.5 ml total suspect of meningococcal A-C-Y-W135 (D CONJ) vaccine Solution for injection (lot number: U7596AB, expiration date: 14-Mar-2025) via intramuscular route in the thigh nos for immunizations (immunisation) with no adverse event (product administered to patient of inappropriate age) (latency: same day).  No lab data reported.  Action taken: not applicable.  Outcome was Unknown for the event menactra was administered to a patient of age 4 month with no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: Incorrect route of product administration, No adverse event
Clinical narrative: yf-vax was given through intramuscular route instead of subcutaneous route with no reported adverse event; Initial information received on 20-Apr-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 58 years old male patient who was given yellow fever vaccine [YF-VAX] through intramuscular route instead of subcutaneous route with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included typhoid vaccine; diphtheria vaccine toxoid, pertussis vaccine acellular 5-component, tetanus vaccine toxoid (Adacel); hepatitis B vaccine (Hepatitis B); and hepatitis A vaccine (Hepatitis A) for Immunisation.  On 20-Apr-2023, the patient received 0.5 mL of dose 1 suspect yellow fever vaccine, solution for injection (lot: UJ818AA; expiry date: 18-Apr-2024) via intramuscular route in the left deltoid for immunization instead of subcutaneous route with no reported adverse event (incorrect route of product administration) (same day latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event yf-vax was given through intramuscular route instead of subcutaneous route with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: M
Vaccine: FLUC3
Symptoms: Condition aggravated, Pain, Peripheral swelling, Wheezing
Clinical narrative: Some wheezing; Arm swelling; Sore; This spontaneous case was retrieved on 18-Apr-2023 from physician via Regulatory Communications (reference number: SEQW23-01243), and concerned a child (born in 2019), male patient.  The patient's medical history included wheezing. The patient's concomitant medications included albuterol, used for unreported indication.   On 10-Oct-2022, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine inact sag 4v; dose: 0.5 ml, route of administration and anatomical location: not reported) for prevention of influenza disease. The batch number was reported as 942377 and the expiry date was 02-Jun-2023.   On the same date, after administration of Flucelvax Quadrivalent, the patient experienced arm swelling, and sore. 60-90 minutes after receiving Flucelvax Quadrivalent, the patient experienced some wheezing. There were no treatment measures associated with the events.   On the same date, the patient recovered from the event of wheezing. Wheezing was resolved quickly.  On unspecified date in Oct-2022, the patient recovered from the events of arm swelling and 'pain'. the arm swelling and sore resolved after a few days.   The reporter did not provide causality assessment.   The case was assessed as non-serious.  Company comment: A child patient (born in 2019) experienced wheezing, peripheral swelling, and pain on the same day, after receiving the suspect product Flucelvax Quadrivalent. Based on suggestive temporal relationship, causality for the reported events is assessed as possibly related.; Sender's Comments: A child patient (born in 2019) experienced wheezing, peripheral swelling, and pain on the same day, after receiving the suspect product Flucelvax Quadrivalent. Based on suggestive temporal relationship, causality for the reported events is assessed as possibly related.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Tinnitus
Clinical narrative: A week after my covid vaccine shot I can hear my heartbeat extremely loud. I still hear it and It extremely hard to do basic task such as reading and listening.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Tinnitus
Clinical narrative: Loud ringing in my left ear
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Deafness unilateral, Tinnitus
Clinical narrative: Tinnitus Right ear within 30 days of second Moderna dose.  Tinnitus came and went for several months and became permanent after about 3 months.  I now have hearing loss in my right ear and permanent tinnitus.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Alopecia, Back pain, Balance disorder, Brain fog
Clinical narrative: Loss of sense of balance, walking difficulty, brain fog, tiredness, backache, heartburn like stomach pain, skin rash, loss of (head)hair.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Disability, Dizziness, Dyspepsia, Economic problem, Fatigue
Clinical narrative: Loss of sense of balance, walking difficulty, brain fog, tiredness, backache, heartburn like stomach pain, skin rash, loss of (head)hair.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Rash, Unemployment, Vision blurred, Weight decreased
Clinical narrative: Loss of sense of balance, walking difficulty, brain fog, tiredness, backache, heartburn like stomach pain, skin rash, loss of (head)hair.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac failure, Laboratory test
Clinical narrative: Went into AFIB 3 days later and then heart failure
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypersomnia, Pyrexia, Tachycardia
Clinical narrative: Idiopathic hypersomnia, fevers when exerting self too much (still currently),  tachycardia.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Cardiac function test abnormal, Carditis, Chest X-ray normal, Chest pain
Clinical narrative: After taking the Moderna booster shot after work around 6:00 PM at the Pharmacy, by the time I got to work the next morning at 8:00 AM I had heart palpitations, severe chest pain and trouble breathing. I immediately left work and my husband drove me to the local Emergency Room. The run an ekg and chest X-ray and tell me I am fine and send me home, saying that I had a bad reaction to the Moderna vaccine. On 2/13/2023, I?m rushed into the Same hospital ER for  the same reason heart palpitations, chest pains and trouble breathing and the hospital admitted me and I was in the cardiac unit for 48 hours. The heart doctor ran every test on my heart and said that I have myocarditis and pericarditis; due to having had Covid 19 three times in the last three years and then taken the Moderna shot three times caused the inflammation of my heart.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram normal, Immunisation reaction, Impaired work ability, Myocarditis
Clinical narrative: After taking the Moderna booster shot after work around 6:00 PM at the Pharmacy, by the time I got to work the next morning at 8:00 AM I had heart palpitations, severe chest pain and trouble breathing. I immediately left work and my husband drove me to the local Emergency Room. The run an ekg and chest X-ray and tell me I am fine and send me home, saying that I had a bad reaction to the Moderna vaccine. On 2/13/2023, I?m rushed into the Same hospital ER for  the same reason heart palpitations, chest pains and trouble breathing and the hospital admitted me and I was in the cardiac unit for 48 hours. The heart doctor ran every test on my heart and said that I have myocarditis and pericarditis; due to having had Covid 19 three times in the last three years and then taken the Moderna shot three times caused the inflammation of my heart.
Sex: U
Vaccine: COVID19
Symptoms: Palpitations, Pericarditis
Clinical narrative: After taking the Moderna booster shot after work around 6:00 PM at the Pharmacy, by the time I got to work the next morning at 8:00 AM I had heart palpitations, severe chest pain and trouble breathing. I immediately left work and my husband drove me to the local Emergency Room. The run an ekg and chest X-ray and tell me I am fine and send me home, saying that I had a bad reaction to the Moderna vaccine. On 2/13/2023, I?m rushed into the Same hospital ER for  the same reason heart palpitations, chest pains and trouble breathing and the hospital admitted me and I was in the cardiac unit for 48 hours. The heart doctor ran every test on my heart and said that I have myocarditis and pericarditis; due to having had Covid 19 three times in the last three years and then taken the Moderna shot three times caused the inflammation of my heart.
Age: 33.0
Sex: M
Vaccine: MMR
Symptoms: Dizziness, Hypotension, Syncope
Clinical narrative: Syncope shortly after taking the vaccine. Blood pressure dropped to a very low rate and almost fainted.
Age: 12.0
Sex: M
Vaccine: HPV9
Symptoms: Autonomic nervous system imbalance, Fatigue, Gait disturbance, Headache, Orthostatic hypotension
Clinical narrative: Started off as minor headaches, fatigue but has progressed to being diagnosed POTS, Orthostatic Hypotension, and Dysautonomia. He has continued headaches, light sensitivity, and can barely walk most days.
Age: 12.0
Sex: M
Vaccine: HPV9
Symptoms: Photophobia, Postural orthostatic tachycardia syndrome
Clinical narrative: Started off as minor headaches, fatigue but has progressed to being diagnosed POTS, Orthostatic Hypotension, and Dysautonomia. He has continued headaches, light sensitivity, and can barely walk most days.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dehydration, Dizziness, Insomnia, Middle insomnia
Clinical narrative: *Extreme lightheadedness* to the point that I had to lie down again before I fainted or fell. I had a hard time sleeping and was up three times during the night, rather than my usual once, so assumed I was dehydrated. After 10 minutes of rehydration, I felt better, and 30 min later I was normal again.
Age: 1.42
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Local reaction, Vaccination site erythema, Vaccination site mass, Vaccination site warmth
Clinical narrative: Mother stated that bilateral thighs had a local reaction from the vaccines stated the Lt thigh had redness, warmth and the lump was a size of a nickel, the RT thigh had the same reaction but the lump had a larger size, the size of a goldball.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Antiphospholipid antibodies negative, Antiphospholipid syndrome, Arthralgia, Beta-2 glycoprotein antibody
Clinical narrative: Conditions developing after vaccine:  extreme exacerbation of all symptoms prior to vaccine. including pain, esp abdominal pain, nauaea, joint/muscle pain, extreme fatigue that is way more then normal, and respitory infections. Altering of pattern of symptoms with the F.M.Fever.  AND NOW APS AND A DYING OR DEAD SPLEEN- (Blood clotting issue)  First vaccination for covid was 6-7-21 and 6-28-21. This was the first set that was produced by Pfizer given at clinic. Age was 62.  After this vaccine I also suffered from the increase in all of my symptoms and the alteration in my pattern of symptoms from FMF. Sadly I did not make the connection untilm after the sec. vaccine for covid 19 in 2022.  Second vaccine was the covid-19 vaccine and it was on Oct. 24th in 2022, This was at another clinic- Age was 64.  First week after vaccine was received, extremely fatigued all over, could hardly move.  Hospital stay was in Nov. of 2022 from exacerbation of symptoms from existing illness. Approx. a 5-6 day stay.  Nov. of 2022, did not sign discharge papers sonce I was kicked out of hosp by Dr. on Nov, 28 th with no reason given.  Dr. did some testing on me trying to see if I may have developed Amyloidosis due to the spleen issue, this is when she discovered the APS (antiphospholipid syndrome) issue and agreed it could be from the vaccine since after the vaccine I experience many symptoms and this had already been reported as after vaccine issues. The test was a set of 3 tests, first one being for the beta 2 glycoprotein ,and mine came back reading 65, and it should be below 20.  The tests include lupus anticoagulant (LA), anticardiolipin (aCL) antibodies (immunoglobulin G [IgG] and IgM), and anti-beta-2 glycoprotein 1 (anti-B2GP1) antibodies (IgG and/or IgM).  I was neg. on the other 2 teats and will retest in June for the Beta 2 test.  *****The Patient has not recovered from reaction to the covid vaccine and covid -19 vaccines. This reaction is life threatening and causing permanent damage to spleen.  At the 2022 vaccine I was also given the flu vaccine for that year, 2022, and have never had any issues from previous flu vaccines which I have gotten almost all of them.  Information on Vaccine lot numbers etc. can be obtained by calling clinic for the info.  I also need you to reach out to my Dr. for her report on this issue as well.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Blood immunoglobulin G normal, Blood immunoglobulin M normal, Brief resolved unexplained event, Cardiolipin antibody negative, Coagulopathy
Clinical narrative: Conditions developing after vaccine:  extreme exacerbation of all symptoms prior to vaccine. including pain, esp abdominal pain, nauaea, joint/muscle pain, extreme fatigue that is way more then normal, and respitory infections. Altering of pattern of symptoms with the F.M.Fever.  AND NOW APS AND A DYING OR DEAD SPLEEN- (Blood clotting issue)  First vaccination for covid was 6-7-21 and 6-28-21. This was the first set that was produced by Pfizer given at clinic. Age was 62.  After this vaccine I also suffered from the increase in all of my symptoms and the alteration in my pattern of symptoms from FMF. Sadly I did not make the connection untilm after the sec. vaccine for covid 19 in 2022.  Second vaccine was the covid-19 vaccine and it was on Oct. 24th in 2022, This was at another clinic- Age was 64.  First week after vaccine was received, extremely fatigued all over, could hardly move.  Hospital stay was in Nov. of 2022 from exacerbation of symptoms from existing illness. Approx. a 5-6 day stay.  Nov. of 2022, did not sign discharge papers sonce I was kicked out of hosp by Dr. on Nov, 28 th with no reason given.  Dr. did some testing on me trying to see if I may have developed Amyloidosis due to the spleen issue, this is when she discovered the APS (antiphospholipid syndrome) issue and agreed it could be from the vaccine since after the vaccine I experience many symptoms and this had already been reported as after vaccine issues. The test was a set of 3 tests, first one being for the beta 2 glycoprotein ,and mine came back reading 65, and it should be below 20.  The tests include lupus anticoagulant (LA), anticardiolipin (aCL) antibodies (immunoglobulin G [IgG] and IgM), and anti-beta-2 glycoprotein 1 (anti-B2GP1) antibodies (IgG and/or IgM).  I was neg. on the other 2 teats and will retest in June for the Beta 2 test.  *****The Patient has not recovered from reaction to the covid vaccine and covid -19 vaccines. This reaction is life threatening and causing permanent damage to spleen.  At the 2022 vaccine I was also given the flu vaccine for that year, 2022, and have never had any issues from previous flu vaccines which I have gotten almost all of them.  Information on Vaccine lot numbers etc. can be obtained by calling clinic for the info.  I also need you to reach out to my Dr. for her report on this issue as well.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Familial mediterranean fever, Fatigue, Laboratory test abnormal, Magnetic resonance imaging
Clinical narrative: Conditions developing after vaccine:  extreme exacerbation of all symptoms prior to vaccine. including pain, esp abdominal pain, nauaea, joint/muscle pain, extreme fatigue that is way more then normal, and respitory infections. Altering of pattern of symptoms with the F.M.Fever.  AND NOW APS AND A DYING OR DEAD SPLEEN- (Blood clotting issue)  First vaccination for covid was 6-7-21 and 6-28-21. This was the first set that was produced by Pfizer given at clinic. Age was 62.  After this vaccine I also suffered from the increase in all of my symptoms and the alteration in my pattern of symptoms from FMF. Sadly I did not make the connection untilm after the sec. vaccine for covid 19 in 2022.  Second vaccine was the covid-19 vaccine and it was on Oct. 24th in 2022, This was at another clinic- Age was 64.  First week after vaccine was received, extremely fatigued all over, could hardly move.  Hospital stay was in Nov. of 2022 from exacerbation of symptoms from existing illness. Approx. a 5-6 day stay.  Nov. of 2022, did not sign discharge papers sonce I was kicked out of hosp by Dr. on Nov, 28 th with no reason given.  Dr. did some testing on me trying to see if I may have developed Amyloidosis due to the spleen issue, this is when she discovered the APS (antiphospholipid syndrome) issue and agreed it could be from the vaccine since after the vaccine I experience many symptoms and this had already been reported as after vaccine issues. The test was a set of 3 tests, first one being for the beta 2 glycoprotein ,and mine came back reading 65, and it should be below 20.  The tests include lupus anticoagulant (LA), anticardiolipin (aCL) antibodies (immunoglobulin G [IgG] and IgM), and anti-beta-2 glycoprotein 1 (anti-B2GP1) antibodies (IgG and/or IgM).  I was neg. on the other 2 teats and will retest in June for the Beta 2 test.  *****The Patient has not recovered from reaction to the covid vaccine and covid -19 vaccines. This reaction is life threatening and causing permanent damage to spleen.  At the 2022 vaccine I was also given the flu vaccine for that year, 2022, and have never had any issues from previous flu vaccines which I have gotten almost all of them.  Information on Vaccine lot numbers etc. can be obtained by calling clinic for the info.  I also need you to reach out to my Dr. for her report on this issue as well.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia, Nausea, Pain, Respiratory tract infection
Clinical narrative: Conditions developing after vaccine:  extreme exacerbation of all symptoms prior to vaccine. including pain, esp abdominal pain, nauaea, joint/muscle pain, extreme fatigue that is way more then normal, and respitory infections. Altering of pattern of symptoms with the F.M.Fever.  AND NOW APS AND A DYING OR DEAD SPLEEN- (Blood clotting issue)  First vaccination for covid was 6-7-21 and 6-28-21. This was the first set that was produced by Pfizer given at clinic. Age was 62.  After this vaccine I also suffered from the increase in all of my symptoms and the alteration in my pattern of symptoms from FMF. Sadly I did not make the connection untilm after the sec. vaccine for covid 19 in 2022.  Second vaccine was the covid-19 vaccine and it was on Oct. 24th in 2022, This was at another clinic- Age was 64.  First week after vaccine was received, extremely fatigued all over, could hardly move.  Hospital stay was in Nov. of 2022 from exacerbation of symptoms from existing illness. Approx. a 5-6 day stay.  Nov. of 2022, did not sign discharge papers sonce I was kicked out of hosp by Dr. on Nov, 28 th with no reason given.  Dr. did some testing on me trying to see if I may have developed Amyloidosis due to the spleen issue, this is when she discovered the APS (antiphospholipid syndrome) issue and agreed it could be from the vaccine since after the vaccine I experience many symptoms and this had already been reported as after vaccine issues. The test was a set of 3 tests, first one being for the beta 2 glycoprotein ,and mine came back reading 65, and it should be below 20.  The tests include lupus anticoagulant (LA), anticardiolipin (aCL) antibodies (immunoglobulin G [IgG] and IgM), and anti-beta-2 glycoprotein 1 (anti-B2GP1) antibodies (IgG and/or IgM).  I was neg. on the other 2 teats and will retest in June for the Beta 2 test.  *****The Patient has not recovered from reaction to the covid vaccine and covid -19 vaccines. This reaction is life threatening and causing permanent damage to spleen.  At the 2022 vaccine I was also given the flu vaccine for that year, 2022, and have never had any issues from previous flu vaccines which I have gotten almost all of them.  Information on Vaccine lot numbers etc. can be obtained by calling clinic for the info.  I also need you to reach out to my Dr. for her report on this issue as well.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Splenic injury, Splenic necrosis
Clinical narrative: Conditions developing after vaccine:  extreme exacerbation of all symptoms prior to vaccine. including pain, esp abdominal pain, nauaea, joint/muscle pain, extreme fatigue that is way more then normal, and respitory infections. Altering of pattern of symptoms with the F.M.Fever.  AND NOW APS AND A DYING OR DEAD SPLEEN- (Blood clotting issue)  First vaccination for covid was 6-7-21 and 6-28-21. This was the first set that was produced by Pfizer given at clinic. Age was 62.  After this vaccine I also suffered from the increase in all of my symptoms and the alteration in my pattern of symptoms from FMF. Sadly I did not make the connection untilm after the sec. vaccine for covid 19 in 2022.  Second vaccine was the covid-19 vaccine and it was on Oct. 24th in 2022, This was at another clinic- Age was 64.  First week after vaccine was received, extremely fatigued all over, could hardly move.  Hospital stay was in Nov. of 2022 from exacerbation of symptoms from existing illness. Approx. a 5-6 day stay.  Nov. of 2022, did not sign discharge papers sonce I was kicked out of hosp by Dr. on Nov, 28 th with no reason given.  Dr. did some testing on me trying to see if I may have developed Amyloidosis due to the spleen issue, this is when she discovered the APS (antiphospholipid syndrome) issue and agreed it could be from the vaccine since after the vaccine I experience many symptoms and this had already been reported as after vaccine issues. The test was a set of 3 tests, first one being for the beta 2 glycoprotein ,and mine came back reading 65, and it should be below 20.  The tests include lupus anticoagulant (LA), anticardiolipin (aCL) antibodies (immunoglobulin G [IgG] and IgM), and anti-beta-2 glycoprotein 1 (anti-B2GP1) antibodies (IgG and/or IgM).  I was neg. on the other 2 teats and will retest in June for the Beta 2 test.  *****The Patient has not recovered from reaction to the covid vaccine and covid -19 vaccines. This reaction is life threatening and causing permanent damage to spleen.  At the 2022 vaccine I was also given the flu vaccine for that year, 2022, and have never had any issues from previous flu vaccines which I have gotten almost all of them.  Information on Vaccine lot numbers etc. can be obtained by calling clinic for the info.  I also need you to reach out to my Dr. for her report on this issue as well.
Age: 1.0
Sex: F
Vaccine: HIBV, MMRV, PNC13
Symptoms: Pallor, Rash erythematous, Rash macular
Clinical narrative: Erythematous macular rash, blanches with pressure, on anterior and posterior torso.
Age: 4.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Covid19 Bivalent vaccine lot #GP4345 had a 10 week expiry of 04/07/2023. Administered vaccine seven days past the BUD on 0/14/2023. We contact Pfizer on 04/18/2023 for Stabilit assessment: Stability dad DOES NOT SUPPORT for our excursion. We will re-vaccinate patient.
Age: 4.0
Sex: F
Vaccine: COVID19-2, DTAPIPV, MMR, VARCEL
Symptoms: Expired product administered
Clinical narrative: Covid19 Bivalent vaccine lot # GP4345 had a 10 week expiry of 04/07/2023 administered past the BUD on 04/0/2023. We contact Pfizer on 04/18/2023 for Stability Assessment: Stability data DOES SUPPORT
Age: 0.75
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Covid19 Bivalent vaccine lot# GP4345 had a 10 week expiry of 04/07/2023. Administered vaccine three days past due  BUD on 04/10/2023. We contact Pfizer on 04/18/2023 for Stability assessment: Stability data DOES SUPPORT. No need to re vaccinated.
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Covid19 Bivalent vaccine lot# GP4345 had a 10 week expiry of 04/07/2023. Administered vaccine three days past due BUD on 04/10/2023. We contact Pfizer on 04/18/2023 for Stability assessment: Stability data DOES SUPPORT. No need to re vaccinated
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Brain fog, Condition aggravated, Decreased appetite, Electrophoresis protein abnormal
Clinical narrative: Pain in leg & sudden increase in neuropathy Blood Pressure abnormally high (over 200) - change in BP medicine has it back to normal Feeling foggy (better now) Decrease in energy level Loss of appetite When I talk, I feel like I'm in a well Off & On tingling in my fingers Face feels puffy & I squint my eyes (comes & goes)